Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Grifols, S.A.

GIFLFPNK
Healthcare
Drug Manufacturers - General
$11.66
$0.001(0.009%)
U.S. Market opens in 5h 7m

Grifols, S.A. (GIFLF) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.8B
P/E Ratio19.97
EPS (TTM)$0.64
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$14.03
3 Months$12.40
1 Year Target$13.45

GIFLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIFLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.97 and a market capitalization of 8.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.64%
5-Day Change
2.98%
1-Month Change
10.63%
3-Month Change
10.63%
6-Month Change
-7.19%
Year-to-Date (YTD) Change
10.63%
1-Year Change
37.23%
3-Year Change
-10.85%
5-Year Change
-51.32%
All-Time (Max) Change
-99.94%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

238,330 Employees
IPO DateJun 24, 2008
CountryES
Actively Trading

Frequently Asked Questions